[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Summit Therapeutics Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$smmt.png) Summit Therapeutics Inc. Common Stock (SMMT)

Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern.

### About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company.  
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the [Stocks](/list/stocks) and  category.

### Insights [#](/topic/$smmt/insights)
- Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) sentiment is up XXXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXX% from the previous week.

### Price: $XX [#](/topic/$smmt/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/close.tsv)  
The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2025-04-24  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$smmt/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/alt_rank.tsv)  
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +535  
**1 Month**: XXX -XXX  
**6 Months**: XXX +129  
**1 Year**: XXX -XX  
**1-Year High**: XXXXX on 2025-08-11  
**1-Year Low**: X on 2025-02-09  
  
  
### Galaxy Score: XXXXX [#](/topic/$smmt/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +4  
**1 Month**: XX -X  
**6 Months**: XX -XX  
**1 Year**: XX +6  
**1-Year High**: XX on 2025-04-22  
**1-Year Low**: X on 2025-03-18  
  
  
### Engagements: XXXXX [#](/topic/$smmt/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +19%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-04-25  
**1-Year Low**: XXX on 2025-09-20  

| Social Network | Reddit | X     | YouTube |
| -------------- | ------ | -     | ------- |
| Engagements    | XX     | XXXXX | X       |
  

  
  
### Mentions: XX [#](/topic/$smmt/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX -XXXX%  
**1 Year**: XXXXXX +62%  
**1-Year High**: XXX on 2025-07-18  
**1-Year Low**: XX on 2025-10-07  

| Social Network | Reddit | X   | YouTube |
| -------------- | ------ | -   | ------- |
| Mentions       | X      | XXX | X       |
  

  
  
### Creators: XX [#](/topic/$smmt/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +33%  
**1 Year**: XXXXX +108%  
**1-Year High**: XXX on 2025-07-18  
**1-Year Low**: XX on 2025-10-07  

The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@Biotech2k1](/creator/twitter/Biotech2k1)         | X    | XXXXXX    | X     | XXXXX       |
| [@FL0WG0D](/creator/twitter/FL0WG0D)               | X    | XXXXXX    | X     | XXX         |
| [@EgrandeBilli](/creator/twitter/EgrandeBilli)     | X    | XXX       | X     | XXX         |
| [@Darensf1](/creator/twitter/Darensf1)             | X    | XXX       | X     | XXX         |
| [@OzmosiHealth](/creator/twitter/OzmosiHealth)     | X    | XXXXX     | X     | XX          |
| [@doepke_michel](/creator/twitter/doepke_michel)   | X    | XXXXX     | X     | XX          |
| [@stocket_rocket](/creator/twitter/stocket_rocket) | X    | XXX       | X     | XX          |
| [@A1PHAEDGE](/creator/twitter/A1PHAEDGE)           | X    | XXX       | X     | XX          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)         | X    | XX        | X     | XX          |
| [@FrenzyCapital](/creator/twitter/FrenzyCapital)   | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$smmt/100)
  
  
### Sentiment: XX% [#](/topic/$smmt/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +53%  
**1 Month**: XX% +16%  
**6 Months**: XX% -XX%  
**1 Year**: XX% +6%  
**1-Year High**: XXX% on 2025-10-06  
**1-Year Low**: XX% on 2025-03-23  

**Most Supportive Themes**
- **Upcoming Phase X Data:** (40%) The anticipation of upcoming Phase X data fuels investor excitement.
- **Bullish Sentiment and Recognition:** (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence.
- **Strategic Partnerships:** (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors.
  
**Most Critical Themes**
- **Competition Intensification:** (3%)  Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market.
- **Conflicting Macroeconomic Signals:** (2%)  Uncertainty is introduced by conflicting macroeconomic signals.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| Reddit  | XX       | X%  | XX      | X%  | X        | X% |
| X       | XXX      | XX% | XXXXX   | XX% | XX       | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XX       | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$smmt/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.039%  
**1 Month**: XXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% -XXXX%  
**1-Year High**: XXXXX% on 2025-04-25  
**1-Year Low**: XXXXXX% on 2025-10-07  
  
  
### Market Dominance: XXXXX% [#](/topic/$smmt/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2025-09-10  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$smmt/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX +$2.20%  
**1 Month**: $XXXXXXXXXXXXXX +$11%  
**6 Months**: $XXXXXXXXXXXXXX -$23%  
**1 Year**: $XXXXXXXXXXXXXX +$0.03%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-04-24  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours

[Tesla, Inc. (TSLA)](/topic/tesla)
[Dave Inc. Class A Common Stock (DAVE)](/topic/$dave)
[Tesla, Inc. (TSLA)](/topic/$tsla)
[Moonft (MTC)](/topic/$mtc)
[Insmed, Inc. (INSM)](/topic/$insm)
[One Cash (ONC)](/topic/$onc)
[IonQ, Inc. (IONQ)](/topic/$ionq)
[NVIDIA Corp. (NVDA)](/topic/$nvda)
[AstraZeneca PLC (AZN)](/topic/$azn)

**Top topics mentioned**
In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours

[stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [coins made in usa](/topic/coins-made-in-usa), [$gsun](/topic/$gsun), [tesla](/topic/tesla), [$9926hk](/topic/$9926hk), [discord](/topic/discord), [$dave](/topic/$dave), [stocks industrials](/topic/stocks-industrials), [$tsla](/topic/$tsla), [$dsa](/topic/$dsa), [stocks basic materials](/topic/stocks-basic-materials), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$mtc](/topic/$mtc), [stocks](/topic/stocks), [china](/topic/china), [$bntx](/topic/$bntx), [$insm](/topic/$insm), [$onc](/topic/$onc), [stocks financial services](/topic/stocks-financial-services), [$cmnd](/topic/$cmnd), [$ionq](/topic/$ionq), [$nvda](/topic/$nvda), [$azn](/topic/$azn), [$pfe](/topic/$pfe), [coins defi](/topic/coins-defi), [advanced micro devices](/topic/advanced-micro-devices), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks communication services](/topic/stocks-communication-services), [$rytm](/topic/$rytm), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$orcl](/topic/$orcl), [$crwv](/topic/$crwv), [$incy](/topic/$incy), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$exel](/topic/$exel), [quarterly earnings](/topic/quarterly-earnings), [$anet](/topic/$anet), [$rapp](/topic/$rapp), [$bmy](/topic/$bmy), [gilead sciences](/topic/gilead-sciences), [$gild](/topic/$gild), [$til](/topic/$til), [coins layer 1](/topic/coins-layer-1), [$mrna](/topic/$mrna), [$nok](/topic/$nok), [coins base ecosystem](/topic/coins-base-ecosystem), [trading strategy](/topic/trading-strategy), [stocks real estate](/topic/stocks-real-estate), [$mdlz](/topic/$mdlz), [$intc](/topic/$intc), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [$run](/topic/$run), [coins lending borrowing](/topic/coins-lending-borrowing), [$abbv](/topic/$abbv), [$mos](/topic/$mos), [$teck](/topic/$teck), [baker](/topic/baker), [$akesf](/topic/$akesf), [$mdgl](/topic/$mdgl), [united states](/topic/united-states), [$rvmd](/topic/$rvmd), [$rna](/topic/$rna), [$dnth](/topic/$dnth), [$idya](/topic/$idya), [$kura](/topic/$kura), [$eose](/topic/$eose), [$clf](/topic/$clf), [$dx](/topic/$dx), [$hbt](/topic/$hbt), [$vtgnpremarket](/topic/$vtgnpremarket), [dd](/topic/dd), [money](/topic/money), [$rbrk](/topic/$rbrk), [$hdb](/topic/$hdb), [$bma](/topic/$bma), [$ypf](/topic/$ypf), [$irdm](/topic/$irdm), [$slde](/topic/$slde), [morgan stanley](/topic/morgan-stanley), [morgan](/topic/morgan), [flood](/topic/flood), [cracks](/topic/cracks), [$agio](/topic/$agio), [$bbio](/topic/$bbio), [$bmrn](/topic/$bmrn), [$alks](/topic/$alks), [$316k](/topic/$316k), [coins arbitrum](/topic/coins-arbitrum), [$prva](/topic/$prva), [$amd](/topic/$amd), [$nflx](/topic/$nflx), [stocks banks](/topic/stocks-banks), [ibm](/topic/ibm), [wall street](/topic/wall-street), [upside](/topic/upside), [$sdgr](/topic/$sdgr)

### Top Social Posts [#](/topic/$smmt/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$SMMT Strong Partnerships Ahead 🚀🚀🚀 The companys collaboration with Akeso in China gives it exclusive North America rights creating future licensing and milestone potential. 👉Only insiders get alerts join before it spikes 🔗"  
[X Link](https://x.com/EgrandeBilli/status/1979731346017882385) [@EgrandeBilli](/creator/x/EgrandeBilli) 2025-10-19T02:08Z XXX followers, XX engagements


"$SMMT Global Collaboration Strength🚀🚀🚀 Summits alliance with Akeso Biopharma accelerates global development of ivonescimab combining innovation and commercial scale. 👉Only insiders get alerts join before it spikes 🔗"  
[X Link](https://x.com/EgrandeBilli/status/1979608865152159818) [@EgrandeBilli](/creator/x/EgrandeBilli) 2025-10-18T18:01Z XXX followers, XXX engagements


"$UTHR/$EXEL/$MDGL/$SMMT: Four commercial-stage biotechs liked but not owned fully valued today buyable on a real sell-off. Smart money watches catalysts (readouts approvals) cash runway and valuation multiples not PR soundbites. Size like a PM buy the reset not the hype"  
[X Link](https://x.com/lintrix_x/status/1979608415661064227) [@lintrix_x](/creator/x/lintrix_x) 2025-10-18T18:00Z 2884 followers, XX engagements


"I got X commercial stage biotech names that I do like but I do not own right now. I would if biotech ever sold off and they got cheap again but I think they are all fully valued right now. They are $UTHR $EXEL $MDGL and $SMMT"  
[X Link](https://x.com/Biotech2k1/status/1979585374755164454) [@Biotech2k1](/creator/x/Biotech2k1) 2025-10-18T16:28Z 32.4K followers, 4400 engagements